{"id":"W4220707728","doi":"10.51731/cjht.2022.296","title":"Nivolumab (Opdivo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Nivolumab; Medicine; Adjuvant; Vial; Cancer drugs; Internal medicine; Cancer; Oncology; Intensive care medicine; General surgery; Health care; Political science","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006071343,0.0003252987,0.0003229136,0.0005956017,0.0002741769,0.0009677002,0.0004336474,0.0004857747,0.009835386],"category_scores_gemma":[0.0008778379,0.00007701197,0.0004819696,0.0004275576,0.0002838809,0.0005159321,0.0004031907,0.000672218,0.00305859],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001751294,"about_ca_system_score_gemma":0.002522543,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01617281,"about_ca_topic_score_gemma":0.04610782,"domain_scores_codex":[0.9996758,0.00007187152,0.00003147083,0.00004676002,0.0001235742,0.00005061381],"domain_scores_gemma":[0.9997049,0.00004787906,0.00005650837,0.00001198346,0.0001375987,0.00004106867],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004040712,0.00005168199,0.0009142374,0.002732242,0.00008427488,0.00009161563,0.00002982331,0.0001856352,0.003509687,0.003168823,0.08578811,0.9030398],"study_design_scores_gemma":[0.0001491041,0.0004013965,0.00287082,0.001807164,0.0001178546,0.0005605085,0.00003953874,0.0001515991,0.004399528,0.0006220091,0.988866,0.0000145706],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.0176121,0.7629322,0.002767612,0.01157733,0.003718059,0.0003608904,0.003154039,0.0003772506,0.1975005],"genre_scores_gemma":[0.2313258,0.5997589,0.01007604,0.01848341,0.00155486,0.0004354228,0.006008531,0.0001114367,0.1322456],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01617281,"threshold_uncertainty_score":0.03290266,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03837833158930708,"score_gpt":0.3267822983119757,"score_spread":0.2884039667226687,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}